In summary, tumor localization, BRAF mutation status, ‘de novo’ metastasis/recurrence disease, MCS, and subsequent IO seem to have prognostic value in univariate analysis (p: 0.036, p < 0.01, p: 0.04, p: 0.03, and p: 0.005, respectively). Here, BRAF is linked to neoplasm.